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Multiple entry receptors can mediate infection of cells by herpes
simplex virus (HSV), permitting alternative pathways for infection
and disease. We investigated the roles of two known entry
receptors, herpesvirus entry mediator (HVEM) and nectin-1, in
infection of neurons in the CNS and the development of enceph-
alitis. Wild-type, HVEM KO, nectin-1 KO, and HVEM/nectin-1 dou-
ble KO mice were inoculated with HSV into the hippocampus. The
mice were examined for development of encephalitis or were
killed at various times after inoculation for immunohistological
analyses of brain slices. Nectin-1 KO mice showed no signs of
disease after intracranial inoculation, and no HSV antigens were
detectable in the brain parenchyma. However, HSV antigens were
detected in non-parenchymal cells lining the ventricles. In the
double KO mice, there was also no disease and no detectable
expression of viral antigens even in non-parenchymal cells, indi-
cating that infection of these cells in the nectin-1 KO mice was
dependent on the expression of HVEM. Wild-type and HVEM KO
mice rapidly developed encephalitis, and the patterns of HSV
replication in the brain were indistinguishable. Thus, expression of
nectin-1 is necessary for HSV infection via the intracranial route
and for encephalitis; HVEM is largely irrelevant. These results
contrast with recent findings that (i) either HVEM or nectin-1 can
permit HSV infection of the vaginal epithelium in mice and (ii)
nectin-1 is not the sole receptor capable of enabling spread of HSV
infection from the vaginal epithelium to the PNS and CNS.
HSV  pathogenesis
We have undertaken studies to determine whether thevarious aspects of disease caused by herpes simplex virus
(HSV) are critically dependent on the same or different entry
receptors. The usual manifestations of HSV disease in humans,
the natural host, are perioral or genital lesions of the skin or
mucosa or lesions on the cornea. The virus can spread from
epithelial cells to neurons and establish latent infections in
sensory and autonomic ganglia. Rarely, the virus also spreads to
the CNS to cause encephalitis or meningitis (1).
Mice can be infected by HSV with manifestations of disease
similar to those found in humans. In addition, the mouse entry
receptors for HSV are paralogs of the human entry receptors (2).
Thus, mice and mice mutated for specific HSV entry receptors
provide excellent models for the study of HSV entry require-
ments in disease.
Binding of HSV to either mouse or human cells can be
mediated by interactions of virion envelope glycoproteins gB or
gC with cell surface heparan sulfate (3). These interactions are
not sufficient for viral entry. Entry requires the binding of at
least two envelope glycoproteins, both gD and gB, to specific cell
surface receptors (4, 5). These interactions activate the fusogenic
activity of gB, a homotrimer, and/or gH-gL, a heterodimer,
resulting in fusion of the virion envelope with a cell membrane
(6, 7).
There are multiple alternative gD receptors, including her-
pesvirus entry mediator (HVEM), nectin-1, nectin-2, and spe-
cific sites in heparan sulfate generated by particular 3-O-
sulfotransferases (2). HSV strains differ in their ability to use
human nectin-2 for cell entry (8, 9), and the mouse forms of
nectin-2 tested are not active for HSV entry (10). Use of
3-O-sulfated heparan sulfate as an entry receptor seems to be
restricted to HSV strains of one serotype (HSV-1 but not
HSV-2), although screening of HSV-1 and HSV-2 strains has not
been extensive (11). HVEM and nectin-1 appear to be the
principal gD-binding entry receptors for both serotypes of HSV
and for both human and mouse cells. One gB receptor, paired
Ig-like receptor alpha (PILR), has been identified, and evi-
dence has been presented that other alternative gB receptors
may exist (5).
In a previous study, wild-type, HVEM KO, nectin-1 KO, and
HVEM/nectin-1 double KO mice were inoculated with HSV via
the intravaginal route to assess the roles of each of these
receptors in infection and disease (12). The results showed that
absence of HVEM had little or no effect on the course of acute
disease. Absence of nectin-1 attenuated disease while still per-
mitting infection of the vaginal epithelium and spread of infec-
tion to the PNS and spinal cord. Infection of the vaginal
epithelium required either nectin-1 or HVEM because HVEM/
nectin-1 double KO mice could not be infected by this route.
Spread of infection to the nervous system could not be assessed
in the double KO mice. This spread was less efficient in the
nectin-1 KO mice, but still occurred, and therefore must have
been mediated by some other entry receptor whose identity was
not determined.
To explore further the requirements for HSV replication and
disease in the CNS, we have inoculated mice intracranially and
directly into the hippocampus. The hippocampus was targeted
because it is commonly severely affected in human encephalitis
(13, 14). The results demonstrate that nectin-1 is indispensable
for HSV infection of neurons and other parenchymal cells in the
brain and for the encephalitis that usually results from HSV
replication of the brain. HVEM was found to have a role in the
infection of non-parenchymal cells of the brain but this infection
had no consequences in terms of disease.
Results
Effect of Mouse Genotype on Disease Symptoms and Survival Follow-
ing Intracranial HSV Inoculations. Two methods were used to
inoculate wild-type, HVEM KO, nectin-1 KO, and double KO
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mice. In a pilot experiment, mice were inoculated by needle and
syringe through the cranium with serial dilutions of HSV in 20
L of fluid, targeting the region of the hippocampus. In all other
experiments, mice were inoculated directly into the granular
layer of the hippocampus, following surgery to provide an
opening in the cranium and by use of a stereotaxic apparatus to
deliver an inoculum of 1 L. All mice were monitored daily and,
in most instances, two to three times per day for signs of
neurological symptoms. Severe signs of disease dictated imme-
diate sacrifice.
Fig. 1 shows the results of the pilot experiment. Both wild-type
and HVEM KO mice were susceptible to the development of
encephalitis. Approximately 400 plaque-forming units (PFU) of
virus per mouse were sufficient to cause severe disease in about
one-half of inoculated mice of either genotype. At the higher
doses of virus, mice had to be killed within 2–4 days of
inoculation because of severe neurological symptoms (seizures,
uncontrolled shaking, unbalanced gait). At the lower doses,
these same symptoms were observed in some mice, but not all,
and at a later time (between 8–13 days following injection). The
nectin-1 KO and double KO mice were totally resistant to any ill
effects of virus inoculation into the brain. They survived without
symptoms of disease for the duration of the experiment (14
days), at doses of HSV up to 100 times that required to cause
disease in one-half of wild-type or HVEM KO mice.
To target the HSV inoculum more precisely to a defined
region of the brain, groups of 4 mice of each genotype were
injected into the granular layer of the hippocampus by stereo-
taxic surgery with 2 106 PFU ofHSV in 1L of fluid. This dose
of virus was chosen to ensure infection of all susceptible mice (a
10-fold lower dose permitted survival of one in four wild-type
mice). All wild-type and HVEM KO mice had to be killed due
to their neurological symptoms within 2 days. All nectin-1 KO
and double KO mice survived without any symptoms of disease
for 14 days. We can conclude that development of neurological
disease required the expression of nectin-1 in the mice.
Effect of Mouse Genotype on HSV Infection and Antigen Expression in
the Brain. HSV infection in the brain was assessed by use of a
polyclonal anti-HSV antiserum to detect viral antigens in brain
sections of mice killed at 24 h after stereotaxic inoculation of
virus, or at later times. Fig. 2A shows images, for mice of all four
genotypes, of the hippocampal region at the injection site. Viral
antigens were readily detected in brain sections from both
wild-type and HVEM KO mice at 24 h, most prominently in the
granular layer of the dentate gyrus and, to a lesser extent, in
other regions of the brain. As described below, HSV antigen
expression was readily detected in multiple areas of the brain at
36–48 h after virus inoculation. No viral antigens could be
detected in brain sections from the double KO mice. Viral
antigens were detected in brain sections from the nectin-1 KO
mice but only in limited regions. These conclusions are based on
the examination of multiple anti-HSV-stained sections obtained
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Fig. 1. Effect of mouse genotype on development of encephalitis following
intracranial inoculation of HSV. Mice of each genotype (n  10–13 mice per
group) were inoculated with 20-L samples of HSV at the doses per mouse
indicated, using a needle and syringe to inject the virus through the scalp and
cranium into the region of the hippocampus, right hemisphere. The mice were
examined once or twice per day for symptoms of encephalitis and killed when
these symptoms occurred. Most wild-type and HVEM KO mice succumbed or
were killed within 4 days of inoculation at the highest two doses of virus or
within 10 days for the lower doses. None of the nectin-1 KO or double KO mice
showed any signs of disease for 14 days.
Fig. 2. Effect of mouse genotype on expression of HSV antigens in the brain
after stereotaxic inoculation of virus. Brain sections were prepared 24 h after
virus inoculation (2 106 PFU per mouse) and stained with anti-HSV antibod-
ies (red). (A) Each quadrant shows a representative section from the hip-
pocampus of the mouse strain indicated (Scale bar, 100 m; note that lower
magnification images are shown for the nectin-1 KO and double KO mice). (B)
A nectin-1 KO mouse was inoculated with virus and, after 24 h, was perfused
with fluorescein-conjugated tomato lectin just before sacrifice and sectioning
of the brain. Tomato lectin binds to the luminal surfaces of ventricles and
blood vessels. Left: tomato lectin staining of the blood vessels and ventricular
wall; middle: HSV antigens in the vicinity of the ventricular wall; right: merge
of these images (Scale bar, 100 m.)
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from the brains of many mice of each genotype (14 wild-type; 15
HVEM KO; 10 nectin-1 KO; and 8 double KO).
Comparisons of bright-field and fluorescent images of stained
sections from the nectin-1 KO mice indicated that the HSV
antigens were localized to ventricular surfaces. To confirm that
the infected cells detected in nectin-1 KO mice were non-
parenchymal cells, some inoculated mice were perfused with
fluorescein-conjugated tomato lectin at the time of sacrifice 24 h
after HSV inoculation. Under the conditions of perfusion,
tomato lectin binds to the surfaces of ventricles and blood vessels
in the brain (15). Fig. 2B shows that viral antigens (red) localized
to cells of a ventricular surface that was also stained with tomato
lectin (green). Blood vessels in this section were stained by the
tomato lectin but not by the anti-HSV antibodies. When nectin-1
KO mice were killed at 2 or 4 days after virus inoculation, no
viral antigens could be detected in brain sections, suggesting that
virus was cleared from the ventricular walls where HSV repli-
cation initially occurred.
Many regions of the brain were infected in wild-type and
HVEM KO mice, as observed in brain sections prepared from
mice killed at 36 to 48 h after virus inoculation. No differences
were noted between these two genotypes in the pattern of HSV
spread in the brain as shown in Fig. 3. Infected areas included the
third ventricle and hypothalamus (A andA), zona incerta (B and
B), piriform cortex (C and C), amygdaloid nucleus (D and D),
hilus of the dentate gyrus (E and E), and fimbria of the
hippocampus (F and F).
Neurons, and to a lesser extent non-neuronal cells, were found
to be infected by HSV and to express viral antigens. Dual-
labeling immunohistochemistry using an antibody specific for
the neuronal nuclear protein, NeuN, and the anti-HSV antibod-
ies showed that neurons in the dentate gyrus of the hippocampus
as well as in the piriform cortex were infected by virus (Fig. 4 A
and B). Also, antibodies specific for the microtubule-associated
protein, MAP2, co-localized with the anti-HSV antibodies in
dendrites and cell bodies of hippocampal neurons (Fig. 4C).
There was enhanced expression of the glial fibrillary acidic
protein (GFAP) in infected regions of the brain and a few
GFAP-positive cells, presumably astrocytes, also expressed HSV
antigen (Fig. 4D) but most did not. Oligodendrocytes also
became infected by HSV, as shown by the co-localization of
anti-CNPase and anti-HSV antibodies (Fig. 4E).
Discussion
We show here that nectin-1 expression is a strict requirement for
HSV infection in the mouse brain parenchyma and for the
development of encephalitis after intracranial inoculation. It is
striking that, in the absence of nectin-1, mice were totally
resistant to any deleterious effects of HSV inoculation directly
into the brain, specifically into the hippocampus. This was the
case even though some infection of non-parenchymal cells was
observed inmice that expressedHVEMbut not nectin-1. HVEM
is not necessarily the only receptor capable of mediating infec-
tion of the non-parenchymal cells; nectin-1 could also be ex-
pressed in these cells in wild-type mice.
It is equally striking that nectin-1 was not required for lethal
neurological disease when HSV was introduced via a peripheral
route, namely by intravaginal inoculation. In this previous study
(12), absence of nectin-1 attenuated disease (fewer mice suffered
severe neurological disease), but nevertheless permitted infec-
tion of the vaginal epithelium (via HVEM) and permitted spread
of virus infection to dorsal root ganglia and the spinal cord (via
as yet unidentified receptors). There was also probably spread of
virus infection to autonomic ganglia, which could have ac-
counted for some morbidity and mortality. Thus, nectin-1 is not
required for HSV to enter neurons of the PNS but is required to
infect neurons of the brain.
Nectin-1 is highly conserved among mammals (16). Previous
studies have shown that nectin-1 is expressed throughout the
nervous system of the mouse and in many neurons of the CNS
and PNS (17). Also, anti-nectin-1 antibodies have been shown to
inhibit the infection of cultured rodent and human primary
sensory neurons (18, 19). Thus, it is not surprising that nectin-1
has a key role in the infection of neurons. There are other entry
receptors expressed in the brain and PNS, however, including
3-O-sulfotransferases (20) that generate gD-binding receptors
potentially capable of substituting for nectin-1 in permitting viral
entry. It remains to be determined whether peripheral neurons
and CNS neurons differ in expression of potential gD receptors.
Available evidence indicates that HVEM is not highly ex-
pressed in the brain (23–26). Presumably, it is expressed in
ependymal cells lining ventricles, however, to account for the
infection of these cells in nectin-1 KOmice but not in double KO
mice. Although nectin-1 is indispensable among the gD-binding
receptors for HSV infection of cells in the brain parenchyma, it
may not be the only entry receptor required. Because a gB
receptor appears to be required along with a gD receptor for
HSV entry, and the gB-binding receptor, PILR, is expressed in
the brain (5), the possibility exists that PILR or another
gB-binding receptor is also required.
Since the known roles of nectin-1 and HVEM in HSV
infection are to mediate the entry of virus into cells, it seems
reasonable to conclude from our results that, in nectin-1 KO or
double KO mice, neurons or other cells at the injection site were
Fig. 3. HSV antigen expression in the brains of wild-type and HVEM KO mice killed at 36 or 48 h after stereotaxic virus inoculation (2  106 PFU per mouse).
The top panels are sections from wild type mice and the bottom panels from HVEM KO mice. (A and A) third ventricle (3V) and hypothalamus (HT); (B and B)
zona incerta (ZI); (C and C) piriform cortex (Pir); (D and D) lateral ventricle (LaDL) and caudate putamen; (E and E) hilus and CA3 of dentate gyrus (DG) in the
hippocampus; (F and F) fimbria (fi) of the hippocampus. Two brain maps (29) at the right represent different coronal sections through the brain at the level of
the hippocampus. The arrows point to the injection target. B–D, F, and F are ipsilateral to the inoculation site and E and E are contralateral, as indicated by
boxes on the brain maps (Scale bar, 50 m.)
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simply resistant to viral entry. This possibility could not be
directly tested by the methods described here. A previous study
(21) showed that fusion of HSV with rodent synaptosomes could
serve as a surrogate assay for viral entry into neurons and as a
way to visualize entry by cryoelectron tomography. Therefore,
we assessed the ability of HSV to fuse with synaptosomes
prepared from the brains of the four strains of mice used here.
The results showed that such fusion could be observed with
synaptosomes from wild-type and HVEM KO mice but not with
those from nectin-1 KO or double KOmice (Fig. S1 and SI Text).
We targeted the hippocampus in this study because this region
of the brain is typically heavily damaged by HSV replication in
human cases of encephalitis (13, 14) and also following exper-
imental challenge of rodents (22, 23). Previous studies in mice
have also targeted the hippocampus by stereotaxic inoculation
(24, 25). Lower doses of virus were used resulting in less
morbidity and mortality. Immunohistochemistry was carried out
at later times than in the present study but gave similar results
with respect to the expression of viral antigens in the hippocam-
pus and in some of its afferent connections. In these studies and
the one reported here, spread of infection was consistent with
known retrograde axonal transport mechanisms of HSV. It has
also been shown that HSV inoculation into the hippocampus
resulted in much more extensive viral infection and pathological
effects than inoculation into the cerebellum (24). The authors of
this study suggested that a selective susceptibility of cells in
telecephalic or limbic structures may account for the patholog-
ical features of HSV encephalitis, including those observed in
acutely infected mice as well as the memory deficits observed in
humans. It remains to be determined whether the distribution of
nectin-1 in the brain can account for this apparent selective
susceptibility.
What is the relevance of our results to human disease?
Obviously, HSV is not usually introduced directly into the brains
of humans. It spreads to the brain from peripheral tissues,
probably via neural routes, at least in adults. Once in the brain,
however, it is likely that HSV infection of neurons and other cells
is largely dependent on nectin-1 expression. For some strains of
HSV, human nectin-2 may substitute as an entry receptor. A
survey of HSV clinical isolates revealed that some HSV-2
isolates from genital lesions and HSV-1 isolates from the brain
were able to infect cells via nectin-2, whereas nearly all HSV-1
andHSV-2 strains were able to infect cells via HVEMor nectin-1
(9). It seems unlikely that HVEM plays much of a role in HSV
encephalitis. The domains of gD that interact with HVEM are
different from those that interact with nectin-1 and nectin-2.
Thus, drugs that can block the interactions of gD with nectin-1
and nectin-2 should be effective at reducing the spread of HSV
within the brain.
Materials and Methods
Mice and Animal Care. Wild-type C57BL/6 mice were obtained from Jackson
Labs. HVEM KO mice back-crossed to C57BL/6 (26) and nectin-1 KO (27) and
double KO mice (12) on a mixed background have been described. PCR analysis
was performed as described (12) to confirm the genotypes of all mutant mice.
The mice were maintained in a specific-pathogen-free facility until just before
inoculation, when they were transferred to a containment facility. Animal
care and use were in accordance with institutional and National Institutes of
Health guidelines, and all studies were approved by the Animal Care and Use
Committee of Northwestern University.
Inoculation of the Mice. HSV-2, strain 333, was used for inoculations of both
male and female mice, aged 6–12 weeks. The virus was diluted in PBS (PBS)
containing 10% glucose and 1% FCS (PBS-G-CS) to yield doses/mouse as
indicated in the text. PBS-G-CS was used for inoculum in control mice. For a
pilot study, groups of mice were inoculated intracranially with 20L of serially
diluted virus, using a 26-gauge needle to penetrate the scalp and cranium over
the hippocampal region of the right hemisphere with a needle guard to
prevent penetration further than 5 mm. For all other experiments, mice were
inoculated by stereotaxic surgery (28). Mice were anesthetized using a con-
tinuous flow of isoflurane and placed on the stereotaxic apparatus. An
incision was made in the scalp and a hand-held drill used to thin the bone over
the injection site. A needle was used to perforate the edges of the thinned
area and to carefully remove a 1-mm diameter piece of the thinned bone. A
finely pulled micropipette was used to inject the virus. Coordinates for the
injection site were: Caudal (-) 2.1 mm; Lateral 1.8 mm; Ventral 2.1 mm. Mice
were monitored daily (usually twice daily) for clinical symptoms of encepha-
litis and overall health. These symptoms included weight loss, ruffled fur,
hunched posture, unbalanced gait, seizures, uncontrolled shaking, scratching
of head, ocular lesions, and paralysis. Mice were killed as soon as the symptoms
indicated significant discomfort.
Tissue Collection and Immunohistochemistry. At the times indicated after virus
inoculation, mice were deeply anesthetized with isoflurane and perfused
transcardially first with PBS (pH 7.2), followed by 4% paraformaldehyde in
Fig. 4. Use of antibodies to cell proteins to identify cell types infected by HSV.
HVEM KO mice were killed at 36 or 48 h after stereotaxic inoculation of HSV
(2 106 PFU per mouse). For each row, the left image shows staining with the
antibody indicated, the middle image is labeled with the anti-HSV antibodies,
and the right image shows the merge of these two images. (A) dorsal dentate
gyrus of the hippocampus, ipsilateral, 36 h; (B) piriform cortex, ipsilateral, 36 h;
(C) hippocampus, ipsilateral, 36 h; (D) hypothalamus and dorsal medial nu-
cleus near the third ventricle, 48 h; (E) zona incerta and thalamic region,
ipsilateral, 48 h (Scale bar, A: 200 m; B–E: 70 m). Arrows point to a few of
the cells in which the cellular antigen and HSV antigens co-localized. Similar
results were obtained with infected wild-type mice.
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PBS. The brain was removed and post-fixed in 4% paraformaldehyde solution
overnight at 4 °C. Forty-micrometer-thick coronal sections were cut, using a
vibratome (Leica). Every sixth section was initially used for staining with
antibodies and other sections also used as needed. Sections were washed with
PBS and preincubated with 5% normal goat serum (NGS, Sigma-Aldrich)
diluted in 0.3% Triton-X solution in PBS for 1 h at room temperature. Sections
were then incubated overnight at 4 °C with primary antibodies, including
rabbit polyclonal anti-HSV-2 (Dako) 1:300; mouse monoclonal anti-NeuN, a
neuronal marker (Chemicon/Millipore) 1:300; mouse monoclonal anti-GFAP,
an astrocyte marker (Sigma) 1:300; mouse monoclonal anti-CNPase, an oligo-
dendrocyte marker (Chemicon/Millipore) 1:300; mouse monoclonal
anti-MAP2, a marker for neuronal cell bodies and neurites (Chemicon/
Millipore)1:300 in working solution (3% NGS, 0.3%Triton-X in PBS). Sections
were then washed six times for 10 min each in PBS before incubation, for 1 h
at room temperature, with secondary antibodies including goat anti-rabbit
IgG (HL) Alexa 568 and several goat anti-mouse IgG Alexa 488 preparations
specific for the isotype of the primary antibody used (Invitrogen/Molecular
Probes). Sections were washed six times for 10 min each in PBS before
mounting on VWR frost-plus charged slides with Vectashield Hard Set Mount-
ing Media with Dapi (Vector Labs). Images were taken with an Olympus XI70
Confocal Microscope.
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